Given that cervical carcinoma cells retain wild-type TP53 expression [106], it is tempting to speculate that it may be possible to at least partially reconstitute the dormant TP53 tumor suppressor pathway in HPV-associated lesions and tumors by artificially modulating DINO levels and/or activity. Here, TP53 is linked to cervical carcinoma.